ZA901945B - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- ZA901945B ZA901945B ZA901945A ZA901945A ZA901945B ZA 901945 B ZA901945 B ZA 901945B ZA 901945 A ZA901945 A ZA 901945A ZA 901945 A ZA901945 A ZA 901945A ZA 901945 B ZA901945 B ZA 901945B
- Authority
- ZA
- South Africa
- Prior art keywords
- formula
- compound
- ace
- inhibitor
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32421389A | 1989-03-15 | 1989-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA901945B true ZA901945B (en) | 1991-01-30 |
Family
ID=23262607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA901945A ZA901945B (en) | 1989-03-15 | 1990-03-14 | Therapeutic agents |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0527720B1 (xx) |
| JP (1) | JPH04503806A (xx) |
| KR (1) | KR920700642A (xx) |
| AT (1) | ATE109981T1 (xx) |
| AU (1) | AU640128B2 (xx) |
| CA (1) | CA2049980A1 (xx) |
| DE (1) | DE69011692T2 (xx) |
| DK (1) | DK0527720T3 (xx) |
| ES (1) | ES2057542T3 (xx) |
| IE (1) | IE65902B1 (xx) |
| IL (1) | IL93744A (xx) |
| WO (1) | WO1990010445A1 (xx) |
| ZA (1) | ZA901945B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0651640A1 (en) * | 1992-07-21 | 1995-05-10 | Knoll AG | Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3542794A1 (de) * | 1985-12-04 | 1987-06-11 | Bayer Ag | Antihypertensives kombinationspraeparat |
-
1990
- 1990-03-07 IE IE81890A patent/IE65902B1/en not_active IP Right Cessation
- 1990-03-12 ES ES90904349T patent/ES2057542T3/es not_active Expired - Lifetime
- 1990-03-12 CA CA002049980A patent/CA2049980A1/en not_active Abandoned
- 1990-03-12 WO PCT/EP1990/000430 patent/WO1990010445A1/en active IP Right Grant
- 1990-03-12 EP EP90904349A patent/EP0527720B1/en not_active Expired - Lifetime
- 1990-03-12 DE DE69011692T patent/DE69011692T2/de not_active Expired - Fee Related
- 1990-03-12 AU AU52616/90A patent/AU640128B2/en not_active Ceased
- 1990-03-12 JP JP2504547A patent/JPH04503806A/ja active Pending
- 1990-03-12 AT AT90904349T patent/ATE109981T1/de not_active IP Right Cessation
- 1990-03-12 DK DK90904349.9T patent/DK0527720T3/da active
- 1990-03-12 KR KR1019910701111A patent/KR920700642A/ko not_active Application Discontinuation
- 1990-03-14 ZA ZA901945A patent/ZA901945B/xx unknown
- 1990-03-14 IL IL9374490A patent/IL93744A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE900818L (en) | 1990-09-15 |
| IL93744A (en) | 1995-06-29 |
| KR920700642A (ko) | 1992-08-10 |
| DE69011692T2 (de) | 1994-12-01 |
| AU640128B2 (en) | 1993-08-19 |
| EP0527720B1 (en) | 1994-08-17 |
| DE69011692D1 (de) | 1994-09-22 |
| EP0527720A1 (en) | 1993-02-24 |
| IL93744A0 (en) | 1990-12-23 |
| ATE109981T1 (de) | 1994-09-15 |
| ES2057542T3 (es) | 1994-10-16 |
| JPH04503806A (ja) | 1992-07-09 |
| WO1990010445A1 (en) | 1990-09-20 |
| CA2049980A1 (en) | 1990-09-16 |
| DK0527720T3 (da) | 1994-12-05 |
| AU5261690A (en) | 1990-10-09 |
| IE65902B1 (en) | 1995-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2303629B (en) | Hydroxamic acids and their use as metalloproteinase inhibitors | |
| GEP20033131B (en) | Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity | |
| UA29450C2 (uk) | Похідні гідроксамової кислоти, спосіб їх одержання, спосіб впливу на хвороби та фармацевтична або ветеринарна композиція, що їх містить | |
| IE894048L (en) | New therapeutically active compound and a process for its¹preparation | |
| BR9814498A (pt) | Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica | |
| ATE184798T1 (de) | Hgh enthaltende pharmazeutische zubereitungen | |
| IL112098A0 (en) | Sulfamate derivatives and pharmaceutical compositions containing them | |
| EG19302A (en) | Compound with gastric acid inhibitory effect and process for its preparation | |
| UA42733C2 (uk) | Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить | |
| ZA881053B (en) | Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration | |
| GEP19991872B (en) | Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same | |
| AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
| IL93744A0 (en) | Therapeutic agents | |
| MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
| EP1027051A4 (en) | ANTITHROMBOTIC AGENTS | |
| UA41326C2 (uk) | Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань | |
| GB1375806A (xx) | ||
| IL89126A0 (en) | Beta-lactam antibiotics,their preparation and pharmaceutical compositions containing them | |
| PT85815A (en) | Process for the preparation of a pharmaceutical compound for the treatment of high blood pressure containig as active ingredient a mixture of proline with a conversion inhibitor of the angiotensine enzyme and thiazide | |
| CA2154485A1 (en) | Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders | |
| IE840198L (en) | Therapeutic use of nafazatrom | |
| EP0980366A4 (en) | ANTITHROMOSIS | |
| PT94787A (pt) | Processo de preparacao de composicoes farmaceuticas para administracao transdermica de corticosteroides e de compostos com actividade fisiologica semelhante | |
| IT1254191B (it) | Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina | |
| JO1519B1 (en) | New compounds (new benzimidazole derivatives are effective as ulcers) |